Index by author

August 1, 2021; Volume 62,Issue 8

  1. Zhang, Chao

    1. Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on <sup>18</sup>F-Fluciclovine PET/CT Guidance
      Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
      Olayinka A. Abiodun-Ojo, Ashesh B. Jani, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Oluwaseun A. Odewole, Funmilayo I. Tade, Shreyas S. Joshi, Viraj A. Master, Bridget Fielder, Raghuveer K. Halkar, Chao Zhang, Subir Goyal, Mark M. Goodman and David M. Schuster
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1089-1096; DOI: https://doi.org/10.2967/jnumed.120.256784

  2. Zhang, Jing

    1. Metallofluorocarbon Nanoemulsion for Inflammatory Macrophage Detection via PET and MRI
      Metallofluorocarbon Nanoemulsion for Inflammatory Macrophage Detection via PET and MRI
      Chao Wang, Benjamin I. Leach, Deanne Lister, Stephen R. Adams, Hongyan Xu, Carl Hoh, Patrick McConville, Jing Zhang, Karen Messer and Eric T. Ahrens
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1146-1153; DOI: https://doi.org/10.2967/jnumed.120.255273

  3. Zheng, Junting

    1. Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with <sup>18</sup>F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
      Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
      Andreas G. Wibmer, Michael J. Morris, Mithat Gonen, Junting Zheng, Hedvig Hricak, Steven Larson, Howard I. Scher and Hebert Alberto Vargas
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1050-1056; DOI: https://doi.org/10.2967/jnumed.120.256602

  4. Zhernosekov, Konstantin

    1. Evaluation of Safety and Dosimetry of <sup>177</sup>Lu-DOTA-ZOL for Therapy of Bone Metastases
      Open Access
      Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases
      René Fernández, Elisabeth Eppard, Wencke Lehnert, Luis David Jiménez-Franco, Cristian Soza-Ried, Matías Ceballos, Jessica Ribbeck, Andreas Kluge, Frank Rösch, Marian Meckel, Konstantin Zhernosekov, Vasko Kramer and Horacio Amaral
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1126-1132; DOI: https://doi.org/10.2967/jnumed.120.255851

  5. Zhou, Rong

    1. Kinetic Modeling of <sup>18</sup>F-(2<em>S,</em>4<em>R</em>)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism
      Kinetic Modeling of 18F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism
      Varsha Viswanath, Rong Zhou, Hsiaoju Lee, Shihong Li, Abigail Cragin, Robert K. Doot, David A. Mankoff and Austin R. Pantel
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1154-1162; DOI: https://doi.org/10.2967/jnumed.120.250977

  6. Zukotynski, Katherine

    1. Overview of the First NRG Oncology–National Cancer Institute Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy
      Emilie Roncali, Jacek Capala, Stanley H. Benedict, Gamal Akabani, Bryan Bednarz, Vikram Bhadrasain, Wesley E. Bolch, Jeffrey C. Buchsbaum, Norman C. Coleman, Yuni K. Dewaraja, Eric Frey, Michael Ghaly, Joseph Grudzinski, Robert F. Hobbs, Roger W. Howell, John L. Humm, Charles A. Kunos, Steve Larson, Frank I. Lin, Mark Madsen, Saed Mirzadeh, David Morse, Daniel Pryma, George Sgouros, Sara St. James, Richard L. Wahl, Ying Xiao, Pat Zanzonico and Katherine Zukotynski
      Journal of Nuclear Medicine August 1, 2021, 62 (8) 1133-1139; DOI: https://doi.org/10.2967/jnumed.120.255547
« Previous (Pages : 18 19 20 21 22 ... 22)next »
Back to top

In this issue